Concepedia

Nabil Kaci

NK

Statistics

Publications

13

Citations

695

H-Index

12

Active since

2011

Affiliations

Inserm(Current)

Université Paris Cité

Hôpital Necker-Enfants Malades

Institut des Maladies Génétiques Imagine

Centre National de la Recherche Scientifique

Nabil Kaci is an author at Inserm specializing in genetics, fgfr3-related disorders, and fibroblast growth factor receptor 3 (fgfr3) disorders.

ORCID

Publications per year

2011–2024

13

Publications

13

Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia

Florence Lorget, Nabil Kaci, Jeff Peng et al. · The American Journal of Human Genetics · 2012 · 209 citations · Full text

, , +6

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model

Davide Komla‐Ebri, Emilie Dambroise, Ina Krämer et al. · Journal of Clinical Investigation · 2016 · 111 citations · Full text

, , +16

FGFR3 mutation causes abnormal membranous ossification in achondroplasia

Federico Di Rocco, Martin Biosse Duplan, Yann Heuzé et al. · Human Molecular Genetics · 2014 · 84 citations

, , +16

A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model

Aurélie Jonquoy, Emilie Mugniery, Catherine Benoist-Lasselin et al. · Human Molecular Genetics · 2011 · 47 citations · Full text

, , +17

Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia

Ludovic Martin, Nabil Kaci, Valentin Estibals et al. · Human Molecular Genetics · 2017 · 47 citations · Full text

, , +17

1–5 of 13